BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30745336)

  • 1. Atrophy, oxidative switching and ultrastructural defects in skeletal muscle of the ataxia telangiectasia mouse model.
    Tassinari V; De Gennaro V; La Sala G; Marazziti D; Bolasco G; Aguanno S; De Angelis L; Naro F; Pellegrini M
    J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in ataxia-telangiectasia.
    Valentin-Vega YA; Maclean KH; Tait-Mulder J; Milasta S; Steeves M; Dorsey FC; Cleveland JL; Green DR; Kastan MB
    Blood; 2012 Feb; 119(6):1490-500. PubMed ID: 22144182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia.
    D'Souza AD; Parish IA; Krause DS; Kaech SM; Shadel GS
    Mol Ther; 2013 Jan; 21(1):42-8. PubMed ID: 23011031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis.
    Choy KR; Watters DJ
    Dev Dyn; 2018 Jan; 247(1):33-46. PubMed ID: 28543935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.
    Sharma NK; Lebedeva M; Thomas T; Kovalenko OA; Stumpf JD; Shadel GS; Santos JH
    DNA Repair (Amst); 2014 Jan; 13():22-31. PubMed ID: 24342190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
    Campbell A; Krupp B; Bushman J; Noble M; Pröschel C; Mayer-Pröschel M
    Hum Mol Genet; 2015 Nov; 24(22):6331-49. PubMed ID: 26310626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.
    Shiloh Y; Lederman HM
    Ageing Res Rev; 2017 Jan; 33():76-88. PubMed ID: 27181190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
    Di Siena S; Campolo F; Gimmelli R; Di Pietro C; Marazziti D; Dolci S; Lenzi A; Nussenzweig A; Pellegrini M
    Cell Death Dis; 2018 Feb; 9(3):314. PubMed ID: 29472706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
    Lavin MF
    DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hallmarks of aging in Ataxia-Telangiectasia.
    Aguado J; Gómez-Inclán C; Leeson HC; Lavin MF; Shiloh Y; Wolvetang EJ
    Ageing Res Rev; 2022 Aug; 79():101653. PubMed ID: 35644374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria at the crossroads of ATM-mediated stress signaling and regulation of reactive oxygen species.
    Lee JH; Paull TT
    Redox Biol; 2020 May; 32():101511. PubMed ID: 32244177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts.
    Garg M; Li L; Godbout R
    Redox Biol; 2024 Feb; 69():102988. PubMed ID: 38096740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia.
    Duecker R; Baer P; Eickmeier O; Strecker M; Kurz J; Schaible A; Henrich D; Zielen S; Schubert R
    Redox Biol; 2018 Apr; 14():645-655. PubMed ID: 29172151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial redox sensing by the kinase ATM maintains cellular antioxidant capacity.
    Zhang Y; Lee JH; Paull TT; Gehrke S; D'Alessandro A; Dou Q; Gladyshev VN; Schroeder EA; Steyl SK; Christian BE; Shadel GS
    Sci Signal; 2018 Jul; 11(538):. PubMed ID: 29991649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of cerebellar microglia in Ataxia-telangiectasia.
    Levi H; Bar E; Cohen-Adiv S; Sweitat S; Kanner S; Galron R; Mitiagin Y; Barzilai A
    Glia; 2022 Mar; 70(3):536-557. PubMed ID: 34854502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ataxia telangiectasia. A prototype of neurological involvement in primary immune deficiencies].
    Liptai Z
    Orv Hetil; 2018 Dec; 159(49):2057-2064. PubMed ID: 30525879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity.
    Erttmann SF; Härtlova A; Sloniecka M; Raffi FA; Hosseinzadeh A; Edgren T; Rofougaran R; Resch U; Fällman M; Ek T; Gekara NO
    Immunity; 2016 Jul; 45(1):106-18. PubMed ID: 27421701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia telangiectasia alters the ApoB and reelin pathway.
    Canet-Pons J; Schubert R; Duecker RP; Schrewe R; Wölke S; Kieslich M; Schnölzer M; Chiocchetti A; Auburger G; Zielen S; Warnken U
    Neurogenetics; 2018 Dec; 19(4):237-255. PubMed ID: 30343341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1.
    Chow HM; Cheng A; Song X; Swerdel MR; Hart RP; Herrup K
    J Cell Biol; 2019 Mar; 218(3):909-928. PubMed ID: 30642892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice.
    Peter Y; Rotman G; Lotem J; Elson A; Shiloh Y; Groner Y
    EMBO J; 2001 Apr; 20(7):1538-46. PubMed ID: 11285218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.